K Kawakami

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Regulatory expectations during product development for tumour vaccines
    K Kawakami
    Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, CBER, FDA, Bethesda, MD 20892, USA
    Dev Biol (Basel) 116:53-9; discussion 69-76. 2004

Detail Information

Publications1

  1. ncbi Regulatory expectations during product development for tumour vaccines
    K Kawakami
    Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, CBER, FDA, Bethesda, MD 20892, USA
    Dev Biol (Basel) 116:53-9; discussion 69-76. 2004
    ..The step-wise approach to regulatory requirements including current good manufacturing practices (cGMPs) and characterization of these vaccines at various stages of product development is discussed...